November 5, 2018 – Executive search firm Ross & Company has placed Michael Doyle as president and CEO of Cota Inc., a real-world data and analytics company based in New York.
“As we continue to scale and deliver on the promise of our technology, the addition of Mike Doyle to lead our team is a significant win for our partners, customers and oncology patients,” said Andrew Pecora, founder and executive chairman of Cota. “I’m so proud that he has chosen to join us at this important stage of our growth. He has spent most of the past three decades as a chief executive officer – much of that time in organizations that also operate at the intersection of healthcare analytics and solutions designed to improve insights and patient outcomes, while reducing the cost of care.”
Mr. Doyle has a lengthy track record providing vision, leadership, innovation and team-building to create business value in investor-backed, rapid-growth, public and private healthcare and technology companies. He joins Cota from QPID Health, where he served as president and chief executive officer from 2012 to 2018.
In 2012, Mr. Doyle acquired QPID Health from Partners Health Care and Massachusetts General Hospital, and established it as a commercial healthcare software technology company. He and his team proceeded to build QPID into a leader in artificial intelligence, machine learning, data science and natural language processing. Mr. Doyle sold QPID to eviCore Healthcare in 2016.
Prior to QPID, Mr. Doyle was CEO and chairman of Medsphere Systems Corp., the developer of OpenVista, an open-source enterprise electronic health record system whose basic source code originated at the Department of Veterans Affairs. Before that, he was president and CEO of Advantedge Health Solutions, where he led the rapid expansion of a cloud-based physician revenue cycle management solution for hospital-based physicians. In addition, Mr. Doyle was founder, CEO, and president of Standish Care, a company he brought public. He also held senior leadership positions with two major integrated healthcare delivery systems: Voluntary Hospitals of America (VHA) and National Medical Enterprises (Tenet). Mr. Doyle is a fellow in the American College of Healthcare Executives (FACHE). He has served on numerous private and public company boards.
“We are at an amazing time in history where technology can finally supplement human clinical judgement for the betterment of the patient, their family and the entire healthcare ecosystem,” said Mr. Doyle. “COTA is in a strategic position to drive value through its unique technical capability and patented Cota Nodal Address system. This game-changing innovation was built by oncologists and data scientists – for oncology – and it’s easy to see the impact that it will make to enable precision medicine at scale.”
Hunt Scanlon has developed a number of key branding opportunities for search firms on our mobile platform. From sponsored content to podcasts, videos and straight-up native brand advertising, you now can reach our expanding audience on the go.
Cota is a real-world data and analytics company that enables providers, payers and life science companies involved in diagnosing and treating complex diseases to optimize the outcomes of individual patients and lower the overall cost of the patient population served.
Veteran Search Firm
Established in 1992, Ross & Company specializes in conducting general management, board of director and vice president level engagements for prominent venture capital and private equity funds whose primary investment focus lies in the healthcare and technology sectors.
Larry Ross is the firm’s managing partner and founder. His search background spans a broad range of senior-level engagements across multiple healthcare industry segments, with a particular emphasis on private equity-backed growth companies. He has successfully recruited across the C-suite and at the board level for venture, growth equity and PE sponsored portfolio companies, as well as for managing directors and operating partners for highly respected funds and sponsors. His client work covers a broad spectrum of asset classes, including concept and seed stage start-ups, middle market and large cap companies and publicly traded corporations.
Mr. Ross is an expert in the healthcare arena and has in-depth knowledge of medical informatics/healthcare information systems, managed care, physician practice management and healthcare services. His background also includes working with biotechnology/life sciences, pharmaceutical, diagnostic and medical device manufacturers.
Contributed by Scott A. Scanlon, Editor-in-Chief; Dale M. Zupsansky, Managing Editor; Stephen Sawicki, Managing Editor; and Andrew W. Mitchell, Managing Editor – Hunt Scanlon Media